Stocks › MDLN
Medline Inc. (MDLN) stock analysis
SKIP 3% confidence · analysed Nov 4, 2026
On Nov 4, 2026, our model rated Medline Inc. (MDLN) SKIP with 3% confidence at a price of $34.09. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 38. Momentum is soft: below the neutral 50 line, but not yet oversold.
MACD is below its signal line, so short-term momentum is pointing down.
The price is below both its 50-day and 200-day moving averages, the classic picture of a downtrend.
Volume is 1.7x its 20-day average, so the latest move has real participation behind it.
Trend structure and money flow
Market structure: bearish structure intact, no fresh break.
The most recent swing high is $43.63 and the swing low is $32.81; traders often treat these as resistance and support.
Fundamentals
The company reports a profit margin of 2.3% and revenue growth of +11.6%.
In its latest quarter it earned $0.50 per share, which beat the $0.32 analysts expected.
Wall Street's average rating is 1.6 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $44.31.
The next earnings report is expected around Nov 4, 2026; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score -0.03 (SKIP). Technicals: RSI 38.27, MACD bearish, price below SMA50. Fundamentals: margin 2.3%, revenue growth 11.6%. Financial results: last EPS surprise +56.2%, next earnings 2026-11-04. Smart Money Concepts: bearish structure intact, no fresh break. FinGPT news read: positive. Reference price $34.09; no trade levels (SKIP).
Past ratings for MDLN
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Nov 4, 2026 | SKIP | 3% | $34.09 | — |
"Move since" compares each call's price with the latest analysed price.
Recent news on MDLN
- Nov 2, 2026: Medline announces participation in the 2026 Jefferies Global Healthcare Conference (GlobeNewswire)
Frequently asked questions
Is MDLN a buy right now?
As of Nov 4, 2026, our automated model rates Medline Inc. (MDLN) SKIP with 3% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Medline Inc. report earnings next?
The next earnings report is expected around Nov 4, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.